Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Surrozen, Inc. (SRZN) ownership amendment reports that 5AM Ventures VII, L.P., 5AM Partners VII, LLC, Kush Parmar and Andrew J. Schwab each beneficially own 697,500 shares, or 3.9% of the common stock. Ventures VII purchased 465,000 common shares and warrants covering 232,500 shares in the second closing under the March 24, 2025 Securities Purchase Agreement on October 20, 2026. 5AM Partners VII is Ventures VII’s sole general partner, and Parmar and Schwab are its managing members; all three share voting and dispositive power over securities held by Ventures VII. Before the closing, the reporting persons’ beneficially owned shares represented 5.8% of Surrozen’s outstanding common stock as of September 30, 2026, adjusted under SEC rules.
Key Figures
Beneficial ownership:697,500 sharesOwnership percentage:3.9%Common shares purchased:465,000 shares+4 more
7 metrics
Beneficial ownership697,500 sharesAmount reported by each of the four reporting persons
Ownership percentage3.9%Percentage of the class reported by each reporting person
Common shares purchased465,000 sharesPurchased by Ventures VII in the October 20, 2026 second closing
Shares underlying warrants232,500 sharesUnderlying Second Closing Warrants purchased by Ventures VII
Prior ownership percentage5.8%Beneficially owned shares as of September 30, 2026, before the second closing, adjusted under SEC rules
Shares outstanding11,753,558 sharesSurrozen common shares outstanding as of August 4, 2026
Shares issued in second closing5,741,605 sharesSurrozen common shares issued in the October 20, 2026 second closing; included in the ownership-percentage calculation
Key Terms
beneficial ownership, shared voting power, shared dispositive power, Second Closing Warrants, +1 more
5 terms
beneficial ownershipfinancial
"aggregate number of securities of the Issuer beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting powerregulatory
"Shared Voting Power 697,500.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared Dispositive Power 697,500.00"
Second Closing Warrantsfinancial
"the “Second Closing Warrants”"
Securities Purchase Agreementfinancial
"Securities Purchase Agreement dated March 24, 2025"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How did the reporting persons calculate their 3.9% SRZN ownership?
The calculation used 11,753,558 Surrozen shares outstanding as of August 4, 2026, plus 5,741,605 shares issued in the second closing, and was adjusted for Second Closing Warrants exercisable within 60 days.
Who shares voting and dispositive power over the SRZN securities held by 5AM Ventures VII?
5AM Partners VII, LLC, Kush Parmar and Andrew J. Schwab share voting and dispositive power over securities held by 5AM Ventures VII, L.P. 5AM Partners VII is the partnership’s sole general partner, and Parmar and Schwab are its managing members.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Surrozen, Inc.
(Name of Issuer)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
86889P208
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
86889P208
1
Names of Reporting Persons
5AM Partners VII, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
697,500.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
697,500.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
697,500.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.9 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP Number(s):
86889P208
1
Names of Reporting Persons
5AM Ventures VII, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
697,500.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
697,500.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
697,500.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.9 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP Number(s):
86889P208
1
Names of Reporting Persons
Kush Parmar
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
697,500.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
697,500.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
697,500.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.9 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP Number(s):
86889P208
1
Names of Reporting Persons
Andrew J. Schwab
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
697,500.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
697,500.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
697,500.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.9 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Surrozen, Inc.
(b)
Address of issuer's principal executive offices:
171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080.
Item 2.
(a)
Name of person filing:
The names of the persons filing this report (collectively, the "Reporting Persons") are:
5AM Ventures VII, L.P. ("Ventures VII")
5AM Partners VII, LLC ("Partners VII")
Kush Parmar ("Dr. Parmar")
Andrew J. Schwab ("Schwab")
The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G/A.
(b)
Address or principal business office or, if none, residence:
c/o 5AM Ventures
4 Embarcadero Center, Suite 3110
San Francisco, CA 94111
(c)
Citizenship:
Ventures VII Delaware
Partners VII Delaware
Dr. Parmar United States
Schwab United States
(d)
Title of class of securities:
Common Stock, $0.0001 par value per share
(e)
CUSIP No.:
86889P208
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Row 9 of each Reporting Person's cover page to this Schedule 13G/A sets forth the aggregate number of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and as of the date of this filing and is incorporated by reference.
The Reporting Persons' beneficial ownership of the Issuer's securities consists of (i) 465,000 shares of common stock (the "Second Closing Shares") and (ii) 232,500 shares underlying warrants (the "Second Closing Warrants" and, together with the Second Closing Shares, the "Second Closing Securities"), in each case that Ventures VII had the right to acquire from the Issuer pursuant to the Securities Purchase Agreement dated March 24, 2025 by and among the Issuer and certain investors, including Ventures VII (the "2025 Purchase Agreement"). Ventures VII purchased the Second Closing Securities on October 20, 2026 in the second closing (the "Second Closing") under the 2025 Purchase Agreement.
Partners VII is the sole general partner of Ventures VII and Dr. Parmar and Schwab are the managing members of Partners VII. Each of Partners VII, Dr. Parmar and Schwab shares voting and dispositive power over the securities held by Ventures VII.
(b)
Percent of class:
Row 11 of each Reporting Person's cover page to this Schedule 13G/A sets forth the percentage of the securities of the Issuer beneficially owned by such Reporting Person as of the date of this filing and is incorporated by reference. The percentage set forth in each row 11 is based upon the sum of (i) 11,753,558 shares of the Issuer's common stock outstanding as of August 4, 2026, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on August 6, 2026 and (ii) 5,741,605 shares of the Issuer's common stock issued in the Second Closing, as reported in the Issuer's Current Report on Form 8-K filed with the SEC on October 20, 2026, adjusted to give effect to the Second Closing Warrants to the extent that such securities may be exercised within 60 days hereof.
As of September 30, 2026 (prior to the Second Closing), the shares beneficially owned by the Reporting Persons represented 5.8% of the Issuer's outstanding common stock, as adjusted in accordance with rules of the SEC.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Row 5 of each Reporting Person's cover page to this Schedule 13G/A sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and as of the date of this filing and is incorporated by reference.
(ii) Shared power to vote or to direct the vote:
Row 6 of each Reporting Person's cover page to this Schedule 13G/A sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and as of the date of this filing and is incorporated by reference.
(iii) Sole power to dispose or to direct the disposition of:
Row 7 of each Reporting Person's cover page to this Schedule 13G/A sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and as of the date of this filing and is incorporated by reference.
(iv) Shared power to dispose or to direct the disposition of:
Row 8 of each Reporting Person's cover page to this Schedule 13G/A sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and as of the date of this filing and is incorporated by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
5AM Partners VII, LLC
Signature:
/s/ Andrew J. Schwab
Name/Title:
By Andrew J. Schwab, Managing Member
Date:
11/16/2026
5AM Ventures VII, L.P.
Signature:
/s/ Andrew J. Schwab
Name/Title:
By 5AM Partners VII, LLC, its General Partner, By Andrew J. Schwab, Managing Member
Date:
11/16/2026
Kush Parmar
Signature:
/s/ Kush Parmar
Name/Title:
Kush Parmar
Date:
11/16/2026
Andrew J. Schwab
Signature:
/s/ Andrew J. Schwab
Name/Title:
Andrew J. Schwab
Date:
11/16/2026
Exhibit Information
Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on April 2, 2025).